News & Updates
Filter by Specialty:

Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world
15 Aug 2024
byJairia Dela Cruz
Up to 3 months of treatment with adjunctive brexpiprazole helps with symptom severity in Asian adults with major depressive disorder (MDD) and inadequate response to antidepressants in a real-life clinical setting in Singapore.
Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world
15 Aug 2024
Brain alterations greater in specific phobia vs other anxiety disorders
14 Aug 2024
Specific phobia is associated with brain alterations that surpass those of other anxiety disorders in terms of effect size and extent, reveals a study. Such changes are not limited to decreases in brain structure.
Brain alterations greater in specific phobia vs other anxiety disorders
14 Aug 2024
Gut microbiota may unlock new diagnostic and treatment strategies for autism
07 Aug 2024
byKanas Chan
Gut microbiota biomarkers show >90 percent sensitivity and specificity in diagnosing autism spectrum disorder (ASD). Gut microbiome modulation with a novel synbiotic formula, SCM06, may alleviate anxiety symptoms in children with ASD, according to researchers from the Chinese University of Hong Kong (CUHK).